Among over 500 obese patients with OSAS, long-term tirzepatide treatment led to significant reductions in body weight, AHI, and oxygen desaturation index, with particularly pronounced benefits in patients with concurrent glucose and lipid metabolism abnormalities (52)
Although several researchers focused on biomedical applications on various hybrid NPs, environmental degradation is poorly investigated
The gradual titration schedule is evidence-based and designed to optimize both efficacy and tolerability over the full treatment course
A few signs that it might be time to reach out include: persistent or worsening nausea that doesnt improve over time frequent vomiting or trouble keeping food and fluids down signs of dehydration, like dizziness, dry mouth, or dark urine severe stomach pain or discomfort In some cases, your doctor might recommend adjusting your dose, slowing down titration, or switching medications
This story was produced by GoodRx and reviewed and distributed by Stacker .